Evidence map›Paper›PMID 38213715›Full record

ArticleAcute medicine & surgery

Dysbiosis of gut microbiota in patients with severe COVID-19.

Kentaro Shimizu, Haruhiko Hirata, Natsuko Tokuhira, Daisuke Motooka, Shota Nakamura, Akiko Ueda, Jotaro Tachino, Moe Koide, Akinori Uchiyama, Hiroshi Ogura and 1 more

Open access · goldAbstract read
In one paragraph

Article in Acute medicine & surgery. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Microbiome-Metabolome Crosstalk as a Driver of COVID-19 Severity.Medical sciences (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Kentaro ShimizuDepartment of Traumatology and Acute Critical Medicine Osaka University Graduate School of Medicine Suita Japan.ORCID https://orcid.org/0000-0003-0631-9365
Haruhiko HirataDepartment of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine Osaka University Osaka Japan.
Natsuko TokuhiraIntensive Care Unit, Osaka University Hospital Osaka University Suita Japan.
Daisuke MotookaDepartment of Infection Metagenomics, Research Institute for Microbial Diseases Osaka University Suita Japan.
Shota NakamuraDepartment of Infection Metagenomics, Research Institute for Microbial Diseases Osaka University Suita Japan.
Akiko UedaLaboratory for Clinical Investigation, Osaka University Hospital Osaka University Suita Japan.
Jotaro TachinoDepartment of Traumatology and Acute Critical Medicine Osaka University Graduate School of Medicine Suita Japan.
Moe KoideIntensive Care Unit, Osaka University Hospital Osaka University Suita Japan.
Akinori UchiyamaIntensive Care Unit, Osaka University Hospital Osaka University Suita Japan.
Hiroshi OguraDepartment of Traumatology and Acute Critical Medicine Osaka University Graduate School of Medicine Suita Japan.
Jun OdaDepartment of Traumatology and Acute Critical Medicine Osaka University Graduate School of Medicine Suita Japan.
The University of Osaka · JPOsaka University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: Altered gut microbiota has been proposed as one of the causes of exacerbation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/COVID-19) from the perspective of the gut-lung axis. We aimed to evaluate gut microbiota in mechanically ventilated patients with COVID-19 prior to using antibiotics. Methods: We retrospectively selected for enrollment COVID-19 patients who required mechanical ventilation on admission but who had not used antibiotics before admission to observe the influence of SARS-Cov-2 on gut microbiota. Fecal samples were collected serially on admission and were evaluated by 16S rRNA gene deep sequencing. Results: The phylum of Bacteroidetes decreased, and those of Firmicutes and Actinobacteria increased in COVID-19 patients compared with those in healthy controls ( Conclusion: The commensal gut microbiota were altered, and opportunistic bacteria increased in patients with severe COVID-19 who required mechanical ventilation on admission.

Indexed as

COVID‐19dysbiosisgutICUmicrobiota

Identifiers

PMID38213715
PMCPMC10781893
OpenAlexW4390745730

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.